As of the end of April, the World Health Organization was tracking 71 coronavirus vaccines in preclinical trials, with five additional candidates already in clinical trials. Given how recently the COVID-19 pandemic began spreading, it might seem promising that there’s already a lot of activity on the immunization front.

With so many potential...

Epidemiologists or "disease detectives" will say it takes at least 10 years, on average, to develop, test and produce a new anti-viral vaccine.

Given this tedious timescale, news that biotech and pharmaceutical firms worldwide are aiming to have a new vaccine against COVID-19 available in as little as only 18 months is historic and unheard of.

The...

B iopharmaceutical manufacturing uses living cells to produce therapies that treat diseases like cancer, diabetes, and autoimmune disorders. Manufacturing medicine using biology presents different challenges from the traditional chemical manufacturing processes that stamp out identical pressed pills.

Biomanufacturing processes are hard to control...

In my capacity as the Chair of the Council of the Manufacturing USA institute directors, I often get asked about trends in U.S. advanced manufacturing. When I receive a question like this, I try to think about advanced manufacturing as broadly as possible — and consider technologies that could stand to benefit most manufacturers, as well as the U.S...

The world can’t stop talking about biopharma’s scientific achievements, but the discussion often avoids the industry’s biggest potential buzzkill: a shortage of properly trained workers to manufacture these new drugs.

There’s no denying that biopharma drugs will play a vital role in the future of medicine. Biologics make up about 40 percent of the...